[Sign in] [Register]   

EIAab logo

EIAab news detail, please contact if you have any questions about online orders and payment.
Parkinson’s Disease (PD) Cell Therapy Relieves Symptoms in Monkeys
Update time:2017-11-27 17:07:58   【 Font: Large  Medium Small

    A study published in Nature shows that symptoms in monkey model of PD by grafting dopamine-producing neurons derived from human induced pluripotent stem cells (IPSCs) into the monkeys’ brains.

    Kyoto University neurosurgeon Jun Takahashi and colleagues generated eight IPSC lines from skin or blood cells collected from seven human subjects—three with PD and four without—and derived dopaminergic progenitors from these cell lines. Then, the researchers grafted the reprogrammed cells into the brains of 2- to 3-year-old-male cynomolgus monkeys that had been treated with the neurotoxin MPTP, which kills dopamine-releasing neurons and result in PD-like movement defects.


     The seven monkeys shows a 40% to 50% improvement in symptoms compared to vehicle-injected controls, such as decreases in tremors and increases in spontaneous movements . The authors confirmed that cells derived from both PD patients and healthy donors made dopamine in vivo, at levels about half that of cells in normal monkeys.

     Next steps may be the researches about safety and efficiency of the cells which will be work in the model. Then we get closer ever in the cell therapy for Parkinson’s disease (PD).


by EIAab organize the information.
Hot Genes
ALCAM ACE KSR2 ASPRO C19orf80 Gdf5 Trap1a Atf2
Top Searches
Ubiquitin ELISA Ubiquitin-protein ligase metalloproteinase Asprosin TRAP1A Tumor necrosis vitamin d
Why choose EIAAB
Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
Further Information
About us Protein center Bank account Distributors Terms & Conditions Career

Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab